Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa, Trans R Soc Trop Med Hyg, vol.96, pp.242-249, 2002. ,
African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults, BMC Infect Dis, vol.10, p.22, 2010. ,
Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo, Clin Infect Dis, vol.48, pp.181-189, 2009. ,
Meningococcal disease: public health burden and control, World Health Stat Q, vol.50, pp.170-177, 1997. ,
Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data, Lancet Infect Dis, vol.12, pp.757-764, 2012. ,
Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity, Clin Infect Dis. Epub, 2012. ,
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomized, double-blind, placebocontrolled trial, Lancet, vol.365, pp.1139-1146, 2005. ,
Emergence of epidemic Neisseria meningtidis serogroup X meningitis in Togo and Burkina Faso, PLoS One, vol.6, p.19513, 2011. ,
Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity, and vaccines, Expert Rev Vaccines, vol.5, pp.319-355, 2006. ,
7-valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?, PLoS One, vol.6, p.26190, 2011. ,
Strengthening public health laboratories in the WHO African Region: a critical need for disease control, The African Health Monitor, vol.12, pp.47-52, 2010. ,
Mobile laboratory to improve response to meningitis epidemics, Burkina Faso epidemic season, FACTS Rep, vol.1, 2004. ,
, Distinguising public health research and public health nonresearch. Science administration document CDC-SA-2010-02. Date of issue, 2010.
Transisolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae, J Clin Microbiol, vol.20, pp.55-58, 1984. ,
Simultaneous Approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis, J Clin Microbiol, vol.38, pp.855-857, 2000. ,
Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing, Clin Infect Dis, vol.40, pp.17-25, 2005. ,
Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger, Clin Infect Dis, vol.44, pp.657-63, 2007. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00561840
Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000, J Clin Microbiol, vol.42, pp.4158-4163, 2004. ,
Standardized nonculture techniques recommended for European reference laboratories, FEMS Microbiol Rev, vol.31, pp.84-88, 2007. ,
Molecular characteristics and epidemiology of meningococcal carriage, Emerg Infect Dis, vol.13, pp.847-854, 2003. ,
The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, Clin Infect Dis, vol.43, pp.817-822, 2002. ,
Outbreaks of serogroup X meningococcal meningitis in Niger, Trop Med Int Health, vol.8, pp.1118-1123, 1995. ,
Prospective study of a serogroup X Neisseria meningtidis outbreak in northern Ghana, J Infect Dis, vol.185, pp.618-626, 2002. ,
An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics, J Infect Dis, vol.192, pp.192-199, 2005. ,
Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso, Clin Infect Dis, vol.43, pp.693-700, 2006. ,